Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20, 1255–1263.
Ackermans, L., Temel, Y., Cath, D., van der Linden, C., Bruggerman, R., Kleijer, M., Nederveen, P., Schruers, K., Colle, H., Tijssen, M.A., Visser-Vandewalle, V., & Dutch Flemish Tourette Surgery Study Group. (2006). Deep brain stimulation in Tourette’s syndrome: two targets? Movement Disorders, 21, 709–713.
Alexander, R.E., & Gage, T.W. (2000). Parkinson’s disease: an update for dentists. General Dentistry, 48, 572–580.
Blanchet, P.J., Allard, P., Gregoire, L., Tardif, F., & Bernard, P.J. (1996). Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients. Canadian Journal of Neurological Science, 23, 189–193.
Blanchet, P.J., Rompre, P.H., Lavingne, G.J., & Lamarche, C. (2005). Oral dyskinesia: a clinical overview. The International Journal of Prosthodontics, 18, 10–19.
Bonifati, V., Rizzi, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., & Dekker, M.C. (2003). Mutation in DJ-1 gene associated with autosomal recessive early – onset parkinsonism. Science, 299, 256–259.
Bower, J.H., Maraganore, D.M., McDonnell, S.K., & Rocca, W.A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota 1976–1990. Neurology, 49, 1284–1288.
Bower, J.H., Maraganore, D.M., & McDonnell, S.K. (1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology, 52, 1214–1220.
Bradford, H., Britto, L.R., Leal, G., & Katz, J. (2004). Endodontic treatment of a patient with Huntington’s disease. Journal of Endodontics, 30, 366–369.
Bressman, S.B. (2000). Dystonia update. Clinical Neuropharmacology, 23, 239–251.
Bressman, S.B., Sabatti, C., Raymond, D., de Leon D, Klein, C., Kramer, P.L., Brin, M.F., Fahn, S., Breakefield, X., Oselius, L.J., & Risch, N.J. (2000). The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 54, 1746–1752.
Chakos, M.H., Alvir, J.M.J., Woerner, M.G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J.M., Borenstein. M., & Lieberman, J.A. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Archives of General Psychiatry, 53, 313–319.
Clifford, T., & Finnerty, J. (1995). The dental awareness and needs of Parkinson’s disease population. Gerontology, 12, 99–103.
Collins, R. (1990). Special considerations for the dental patient with Parkinson’s disease. Texas Dentistry Journal, 107, 31–33.
Comings, D.E., Himes, J.A., & Comings, B.G. (1990). An epidemiologic study of Tourette’s syndrome in a single school district. Journal of Clinical Psychiatry, 51, 463–469.
Deuschl, G., & Elble, R.J. (2000). The pathophysiology of essential tremor. Neurology, 54 (suppl. 4), S14–S20.
Dujardin, K., Defbvre, L., & Grunberg, C. (2001). Memory and executive function in sporadic and familial Parkinson’s disease. Brain, 123, 115–1160.
Fahn, S., Bressman, S.B., & Marsden, C.D. (1998). Classification of dystonia. Advances in Neurology, 78, 1–10.
Feeney, A.W. (1985). Dental treatment considerations for patients with Huntington’s chorea: a literature review and case report. Journal of Connecticut State Dental Association, 59, 118–123.
Findley, L.J. (2000). Epidemiology and genetics of essential tremor. Neurology, 54 (suppl 4),S8–S13.
Friedlander, A.H., & Cummings, J.L. (1992). Dental treatment of patients with Gilles de la Tourette’s syndrome. Oral Surgery, Oral Medicine and Oral Pathology, 73, 299–303.
Frucht, S., Fahn, S., Ford, B., & Gelb, M. (1999). A geste antagoniste device to treat jaw – closing dystonia. Movement Disorders, 14, 883–886.
Fukayo, S., Nonaka, K., Shimizu, T., & Yano, E. (2003). Oral health of patient with Parkinson’s disease: factors related to their better dental status. Tohoku Journal of Experimental Medicine, 201, 171–179.
Geene, P., Kahn, U.J., & Fahn, S. (1995). Spread of symptoms in idiopathic torsion dystonia. Movement Disorders, 10, 143–152.
Golbe, L.I., Davis, P.H., Schoenberg, B.S., & Duvoisin, R.C. (1988). Prevalence and natural history of progressive supranuclear palsy. Neurology, 38, 1031–1034.
Greene, P., Shale, H., & Fahn, S. (1988). Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Advances in Neurology, 50, 547–556.
Jankovic, J. (2004). Dystonia: medical therapy and botulinum toxin. Advances of Neurology, 94, 275–286.
Jeste, D.V., & Wyatt, R.J. (1982). Therapeutic strategies against tardive dyskinesia; two decades of experience. Archives of Psychiatry, 39, 803–816.
Jost, W.H., & Kohl, A. (2001). Botulinum toxin: evidence-based medicine criteria in rare indications. Journal of Neurology, 248 (suppl 1), 39–44.
Kane, J.M., & Smith, J.M. (1982). Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry, 39, 473–481.
Kane, J.M., Woerner, M., Borenstein, M., Wegner, J., & Lieberman, J. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254–258.
Kelleher, M.G.D., Scott, B.J.J., & Djemal, S. (1998). Case report: Complications of rehabilitation using osseointegrated implants – tardive dyskinesia. European Journal of Prosthodontics and Restorative Dentistry, 6, 133–136.
Kitada, T., Asakawa, S., Hattori, N., &Yamamura, Y. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605–608.
Kokmen, E., Ozekmekci, F.S, Beard, C.M,, O’Brien, P.C, & Kurland, L.T. (1994). Incidence and prevalence of Huntington’s disease in Olmsted County, Minnesota (1950 through 1989). Archives of Neurology, 51, 696–698.
Koller, W.C. (1983). Edentulous orodyskinesia. Annals of Neurology, 13, 97–99.
Koller, W.C., Hristova, A., & Brin, M. (2000a). Pharmacologic treatment of essential tremor. Neurology, 54 (suppl 4), S30–S38.
Koller, W.C., Pahwa, R., Lyons, K.E., & Wilkinson, S.B. (2000b). Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology, 55 (suppl 6), S29–S33.
Kramer, P.L., Mineta, M., Klein, C., Schilling K, de Leon, D., Farlow, M.R., Breakefield, X.O., Bressman, S.B., Dobyns, W.B., Ozelius, L.J, & Brashear. A. (1999). Rapid onset dystonia-parkinsonism: linkage to chromosome 19q13. Annals of Neurology, 46, 176–182.
Kurlan, R. (2003). Tourette’s syndrome: are stimulants safe? Current Neurology and Neuroscience Reports, 3, 285–288.
Kwak, C.H., Hanna, P.A., Jankovic, J. (2000). Botulinum toxin in the treatment of tics. Archives of Neurology, 57, 1190–1193.
Langston, J.W., Forno, L.S., Tetrud, J., Reeves, A.G., Kaplan, J.A., & Karluk, D. (1999). Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl-4-phenyl–1,2,3,6–tetrahydropyridine exposure. Annals of Neurology, 46, 598–605.
Lauciello, F., & Appelbaum, M. (1977). Prosthodontic implication of tardive dyskinesia. New York State Dentistry Journal, 43, 214–217.
Leksell,E., & Edvardson, S. (2005). A case of Tourette syndrome presenting with oral self-injurious behavior. International Journal of Pediatric Dentistry, 15, 370–374.
Litvan, I., MacIntyre, A., Goetz, C.G., Wenning, G.K., Jellinger, K., Verny, M., Bartko, J.J., Jankovic, J., McKee, A., Brandel, J.P., Chaudhuri, K.R., Lai, E.C., D’Olhaberriaque, L., Pearce, R.K., & Agid, Y. (1998). Accuracy of the clinical diagnoses of Lewy body disease, Parkinson’s disease and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology, 55, 969–978.
Litvan, I., Grimes, D.A., Lang, A.E., Jankovic, J., McKee, A., Verny, M., Jellinger, K., Chaundhuri, K.R., & Pearce, R.K. (1999). Clinical feature differentiating patient with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 ( suppl 2), II1–II5.
Lo, S.E., Gelb, M., & Frucht, S.J. (2007). Geste antogoniste in idiopathic lower cranial dystonia. Movement Disorders, 22, 1012–1017.
Lozano, A.M., & Abosch, A. (2004). Pallidal stimulation for dystonia. Advances in Neurology, 94, 301–308.
McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O’Brien, J.T., Feldman, H., Cummings, J., Duda, J.E., Lippa, C., & Perry, E.K. (2005). Diagnosis and management of dementia with Lewy bodies: third report on the DLB consortium. Neurology, 65, 1863–1872.
Mink, J.W. (2001). Basal ganglia dysfunction in Tourette’s syndrome: a new hypothesis. Pediatrics Neurology, 25, 190–198.
Nakayama, Y., Washio, M., & Mori, M. (2004). Oral health conditions in patients with Parkinson’s disease. Journal of Epidemiology, 14, 143–150.
Nutt, J.G., Muenter, M.D., Aronson, A., Kurland, L.T., & Melton, L.J. 3rd. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Movement Disorders, 3,188–194.
Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sosi, V., Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J., & Freeman, T.B. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Annals of Neurology, 54,403–414.
Paisan-Ruiz, C., Lang, A.E., Kawarai, T., & Sato, C. (2005). LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology, 65, 696–700.
Polymeropoulos, M.H., Lavedan, C., & Leroy, E. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 276, 2045–2047.
Pradhan, S., Pander, N., Shashank, S., Gupta, R.K., & Mathur, A. (1999). Parkinsonism due to predominant involvement of substantia nigra in Japanese Encephalitis. Neurology, 53,1781–1786.
Rajput, A.H. (1994). Clinical features and natural history of Parkinson’s disease (Special consideration of aging). In: D.B. Calne (Eds.), Neurodegenerative diseases (pp. 555–571). Philadelphia: WB Saunders.
Riley, D., & Lang, A.E. (1989). Pain in Gilles de la Tourette’s syndrome and related tic disorders. Canadian Journal of Neurological Science, 16, 439–441.
Rodriquez-Oroz, M.C., Obeso, J.A., Lang, A.E., Houeto, J.L. , Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M.I., Quinn, N.P., Speelman, J.D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedno, B., Pidoux, B., Bonnet, A.M., Ajid, Y., Xie, J., Benabid, A.L., Lozano, A.M., Saint-Cyr, J., Romito, L., Contarino, M.F., Scerrati, M., Fraix, V., & Van Blercom, N. (2005). Bilateral deep brain stimulation in Parkinson’s disease: a multicentral study with 4 years follow – up. Brain, 128, 2240–2249.
Saito, Y., Matsuoka, Y., Takahashi, A., & Ohno, Y. (1994). Survival of patients with multiple system atrophy. Internal Medicine, 33, 321–325.
Sankhla, C., Lai, E.C., & Jankovic, J. (1998). Peripherally induced oromandibular dystonia. Journal of Neurology, Neurosurgery and Psychiatry, 65, 722–728.
Santacruz, P., Uttl, B., Livan, I., & Grafman, J. (1998). Progressive supranuclear palsy: A survery of the disease course. Neurology, 50, 1637–1647.
Schoenberg, B.S., Anderson, D.W., & Haerer, A.F. (1985). Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology, 35, 841–845.
Schrag, A., Ben-Shlomo, Y., & Quinn, N.P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross – sectional study. Lancet, 354, 1771–1775.
Schrag, A., Bhatia, K.P, Quinn, N.P, & Marsden, C.D. (1999). Atypical and typical cranial dystonia following dental procedures. Movement Disorders, 14, 492–496.
Segawa, M., Hosaka, A., Miyagawa, F., Nomura, Y., & Imai H. (1976). Hereditary progressive dystonia with marked diurnal fluctuation. Advances in Neurology, 14, 215–233.
Sejvar, J.J., Haddad, M.B., Tierney, B.C., Campbell, G.L., Marfin, A.A., Van Gerpen, J.A., Fleischauer, A., Leiss, A.A., Stokic, D.S., & Petersen, L.R . (2003). Neurologic manifestations and outcome of West Nile Virus infection. Journal of American Medical Association, 290, 511–515.
Shahed, J., Poysky, J., Kenney, C., Simpson, R., & Jankovic, J. (2007). GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbilities. Neurology, 68, 159–160.
Singer, C. (1997). Tourette syndrome. Coprolalia and other coprophenomena. Neurological Clinics, 15, 299–308.
Sutcher, H., Soderstrom, J., Perry, R., & Das, A. (1998). Tardive dyskinesia: dental prosthetic therapy. Panminerva medica, 40, 154–156.
Sutcher, H.D., Underwood, R.B., Beatty, R.A., & Sugar O. (1971). Orofacial dyskinesia – a dental dimension. Journal of American Medical Association, 216, 1459–1463.
Tanner, C.M. (1992). Occupational and environmental causes of parkinsonism. Occupational Medicine, 7, 503–513.
Uc, E.Y., Rizzo, M., Anderson, S.W., & Qian, S. (2005). Visual dysfunction in Parkinson disease without dementia. Neurology, 65, 1907–1913.
Volkmann, J., Allert, N., Vodes, J., Weiss, P.H., Freund, H.J., & Sturm, V. (2001). Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology, 57, 1354–1358.
Waddy, H.M., Fletcher, N.A,, Harding, A.E., Marsden, C.D. (1991). A genetic study of idiopathic dystonias. Annals of Neurology, 29, 320–324.
Woody, R.C., & Eisenhauer, G. (1986). Tooth extraction as a form of self- mutilation in Tourette’s disorder. South Medical Journal, 79, 1466.
Yoshikawa, F., Takagi, T., Fukayama, H., Miwa, Z., & Umino, M. (2002). Intravenous sedation and general anesthesia for a patient with Gilles de la Tourette’s syndrome undergoing dental treatment. Acta Anasthesiologica Scandinavia, 46, 1279–1280.
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007). Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. New England Journal of Medicine, 356, 39–46.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Browner, N.M., Frucht, S. (2008). Movement Disorders in Dental Practice. In: Lamster, I.B., Northridge, M.E. (eds) Improving Oral Health for the Elderly. Springer, New York, NY. https://doi.org/10.1007/978-0-387-74337-0_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-74337-0_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-74336-3
Online ISBN: 978-0-387-74337-0
eBook Packages: MedicineMedicine (R0)